These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36426751)

  • 1. Transparent Exploration of Machine Learning for Biomarker Discovery from Proteomics and Omics Data.
    Torun FM; Virreira Winter S; Doll S; Riese FM; Vorobyev A; Mueller-Reif JB; Geyer PE; Strauss MT
    J Proteome Res; 2023 Feb; 22(2):359-367. PubMed ID: 36426751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence for proteomics and biomarker discovery.
    Mann M; Kumar C; Zeng WF; Strauss MT
    Cell Syst; 2021 Aug; 12(8):759-770. PubMed ID: 34411543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress of feature selection and machine learning methods for mass spectrometry-based protein biomarker discovery].
    Xu K; Han M; Huang C; Chang C; Zhu Y
    Sheng Wu Gong Cheng Xue Bao; 2019 Sep; 35(9):1619-1632. PubMed ID: 31559744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker discovery studies for patient stratification using machine learning analysis of omics data: a scoping review.
    Glaab E; Rauschenberger A; Banzi R; Gerardi C; Garcia P; Demotes J
    BMJ Open; 2021 Dec; 11(12):e053674. PubMed ID: 34873011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ProteomicsML: An Online Platform for Community-Curated Data sets and Tutorials for Machine Learning in Proteomics.
    Rehfeldt TG; Gabriels R; Bouwmeester R; Gessulat S; Neely BA; Palmblad M; Perez-Riverol Y; Schmidt T; Vizcaíno JA; Deutsch EW
    J Proteome Res; 2023 Feb; 22(2):632-636. PubMed ID: 36693629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing an In Silico Strategy to Select Tissue-Leakage Biomarkers Using the Galaxy Framework.
    Nguyen L; Brun V; Combes F; Loux V; Vandenbrouck Y
    Methods Mol Biol; 2019; 1959():275-289. PubMed ID: 30852829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corra: Computational framework and tools for LC-MS discovery and targeted mass spectrometry-based proteomics.
    Brusniak MY; Bodenmiller B; Campbell D; Cooke K; Eddes J; Garbutt A; Lau H; Letarte S; Mueller LN; Sharma V; Vitek O; Zhang N; Aebersold R; Watts JD
    BMC Bioinformatics; 2008 Dec; 9():542. PubMed ID: 19087345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of machine learning to proteomics data: classification and biomarker identification in postgenomics biology.
    Swan AL; Mobasheri A; Allaway D; Liddell S; Bacardit J
    OMICS; 2013 Dec; 17(12):595-610. PubMed ID: 24116388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using machine learning approaches for multi-omics data analysis: A review.
    Reel PS; Reel S; Pearson E; Trucco E; Jefferson E
    Biotechnol Adv; 2021; 49():107739. PubMed ID: 33794304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oktoberfest: Open-source spectral library generation and rescoring pipeline based on Prosit.
    Picciani M; Gabriel W; Giurcoiu VG; Shouman O; Hamood F; Lautenbacher L; Jensen CB; Müller J; Kalhor M; Soleymaniniya A; Kuster B; The M; Wilhelm M
    Proteomics; 2024 Apr; 24(8):e2300112. PubMed ID: 37672792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivative component analysis for mass spectral serum proteomic profiles.
    Han H
    BMC Med Genomics; 2014; 7 Suppl 1(Suppl 1):S5. PubMed ID: 25080317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. -Omics biomarker identification pipeline for translational medicine.
    Bravo-Merodio L; Williams JA; Gkoutos GV; Acharjee A
    J Transl Med; 2019 May; 17(1):155. PubMed ID: 31088492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology.
    Krasny L; Huang PH
    Mol Omics; 2021 Feb; 17(1):29-42. PubMed ID: 33034323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of technologies for MS-based proteomics-centric multi-omics.
    Rajczewski AT; Jagtap PD; Griffin TJ
    Expert Rev Proteomics; 2022 Mar; 19(3):165-181. PubMed ID: 35466851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Discrimination of Disease States Using Proteomics Data with the Updated Aristotle Classifier.
    Hua D; Desaire H
    J Proteome Res; 2021 May; 20(5):2823-2829. PubMed ID: 33909976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-Mart: Interactive Analysis of Ion Abundance Global Proteomics Data.
    Bramer LM; Stratton KG; White AM; Bleeker AH; Kobold MA; Waters KM; Metz TO; Rodland KD; Webb-Robertson BM
    J Proteome Res; 2019 Mar; 18(3):1426-1432. PubMed ID: 30667224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based clinical proteomics.
    Pusch W; Flocco MT; Leung SM; Thiele H; Kostrzewa M
    Pharmacogenomics; 2003 Jul; 4(4):463-76. PubMed ID: 12831324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coherent pipeline for biomarker discovery using mass spectrometry and bioinformatics.
    Al-Shahib A; Misra R; Ahmod N; Fang M; Shah H; Gharbia S
    BMC Bioinformatics; 2010 Aug; 11():437. PubMed ID: 20796299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery.
    Ledesma D; Symes S; Richards S
    Curr Med Chem; 2021; 28(32):6512-6531. PubMed ID: 33557728
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.